
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Direxion NASDAQ-100 Equal Weighted Index Shares (NASDAQ:QQQE) through any online brokerage.
There are no as such competitors for Direxion NASDAQ-100 Equal Weighted Index Shares.
There is no analysis for Direxion NASDAQ-100 Equal Weighted Index Shares to provide a consensus price target.
The stock price for Direxion NASDAQ-100 Equal Weighted Index Shares (NASDAQ: QQQE) is $104.21 last updated December 15, 2025 at 7:53 AM EST.
There are no upcoming dividends for Direxion NASDAQ-100 Equal Weighted Index Shares.
Direxion NASDAQ-100 Equal Weighted Index Shares does not have any upcoming earnings scheduled.
There is no upcoming split for Direxion NASDAQ-100 Equal Weighted Index Shares.
| Sector | Technology |
| Category | High Performer-High Growth |
| Investment Style | Large Cap Growth |
| Fund Inception | Mar 21, 2012 |
| Managers | Tony Ng Paul Brigandi |
| Definition | An equity fund portfolio full of stocks with both strong financial performance and superior growth potential |
| Symbol | Name | Share % |
|---|---|---|
| WBD | Warner Bros Discovery ... | 1.23% |
| LN | Astrazeneca Plc, ADR | 1.22% |
| AMD | Advanced Micro Devices... | 1.36% |
| INTC | Intel Corp. | 1.24% |
| AMAT | Applied Materials, Inc... | 1.31% |
| MU | Micron Technology, Inc... | 1.41% |
| LRCX | Lam Research Corp | 1.22% |
| ISRG | Intuitive Surgical Inc... | 1.30% |
| REGN | Regeneron Pharmaceutic... | 1.32% |
| BIIB | Biogen Inc. | 1.27% |
A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.